Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
This study is ongoing, but not recruiting participants.
Study NCT01580397   Information provided by CytRx

First Received on April 13, 2012.   Last Updated on February 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pancreatic Ductal Adenocarcinoma
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Carcinoma, Ductal, Breast
Carcinoma, Pancreatic Ductal
Pancreatic Neoplasms
More general conditions related to this trial
Breast Diseases
Breast Neoplasms
Carcinoma
Carcinoma, Ductal
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Ductal, Lobular, and Medullary
Neoplasms, Glandular and Epithelial
Pancreatic Diseases
Skin Diseases
Interventions listed in this trial
INNO-206
Additional drug interventions recognized in this trial
Doxorubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
CytRx


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services